HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reduced Reverse Cholesterol Transport Efficacy in Healthy Men with Undesirable Postprandial Triglyceride Response.

Abstract
Elevation of nonfasting triglyceride (TG) levels above 1.8 g/L (2 mmol/L) is associated with increased risk of cardiovascular diseases. Exacerbated postprandial hypertriglyceridemia (PP-HTG) and metabolic context both modulate the overall efficacy of the reverse cholesterol transport (RCT) pathway, but the specific contribution of exaggerated PP-HTG on RCT efficacy remains indeterminate. Healthy male volunteers (n = 78) exhibiting no clinical features of metabolic disorders underwent a postprandial exploration following consumption of a typical Western meal providing 1200 kcal. Subjects were stratified according to maximal nonfasting TG levels reached after ingestion of the test meal into subjects with a desirable PP-TG response (GLow, TG < 1.8 g/L, n = 47) and subjects with an undesirable PP-TG response (GHigh, TG > 1.8 g/L, n = 31). The impact of the degree of PP-TG response on major steps of RCT pathway, including cholesterol efflux from human macrophages, cholesteryl ester transfer protein (CETP) activity, and hepatic high-density lipoprotein (HDL)-cholesteryl ester (CE) selective uptake, was evaluated. Cholesterol efflux from human macrophages was not significantly affected by the degree of the PP-TG response. Postprandial increase in CETP-mediated CE transfer from HDL to triglyceride-rich lipoprotein particles, and more specifically to chylomicrons, was enhanced in GHigh vs GLow. The hepatic HDL-CE delivery was reduced in subjects from GHigh in comparison with those from GLow. Undesirable PP-TG response induces an overall reduction in RCT efficacy that contributes to the onset elevation of both fasting and nonfasting TG levels and to the development of cardiometabolic diseases.
AuthorsAlexandre Motte Motte, Julie Gall Gall, Joe-Elie Salem, Eric Dasque, Martine Lebot, Eric Frisdal, Sophie Galier, Elise F Villard, Elodie Bouaziz-Amar, Jean-Marc Lacorte, Beny Charbit, Wilfried Le Goff, Philippe Lesnik, Maryse Guerin
JournalBiomolecules (Biomolecules) Vol. 10 Issue 5 (05 25 2020) ISSN: 2218-273X [Electronic] Switzerland
PMID32466286 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CETP protein, human
  • Cholesterol Ester Transfer Proteins
  • Cholesterol Esters
  • Chylomicrons
  • HDL cholesteryl ester
  • Lipoproteins, HDL
  • Triglycerides
  • Cholesterol
Topics
  • Adult
  • Cholesterol (metabolism)
  • Cholesterol Ester Transfer Proteins (metabolism)
  • Cholesterol Esters (metabolism)
  • Chylomicrons (metabolism)
  • Humans
  • Hypertriglyceridemia (metabolism)
  • Lipoproteins, HDL (metabolism)
  • Liver (metabolism)
  • Macrophages (metabolism)
  • Male
  • Postprandial Period
  • Triglycerides (blood, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: